PLOS One Retracts Atrial Fibrillation Study Over Image Duplication Concerns
PLOS One has retracted a study on hydrogen signaling in atrial fibrillation following extensive image overlap and data reliability issues.
PLOS One has retracted a study on hydrogen signaling in atrial fibrillation following extensive image overlap and data reliability issues.
Frontiers in Pharmacology retracted a 2022 article on fisetin and retinal cell damage due to the use of a previously ...
Frontiers in Pharmacology has retracted a bone biology study after an investigation uncovered unresolvable image integrity concerns across multiple figures.
PLOS ONE has retracted a mouse study on pyrroloquinoline quinone after duplicated and overlapping image panels were found across multiple ...
PLOS ONE has retracted a study claiming resveratrol kills osteosarcoma cancer stem cells via STAT3 inhibition after overlapping images, flawed ...
PLOS ONE retracted a Syzygium heyneanum study after editors raised concerns about duplicated-looking images, repetitive table values and the integrity ...
Editors at BMC Complementary Medicine and Therapies have retracted a 2021 study on fucoidan's antitumor effects in lung cancer cells ...
BMC Cancer editors have retracted a 2022 study claiming lycorine blocks tumor blood supply by docking to PDGFRα, citing overlapping ...
BMC Cancer has retracted a 2021 study on LINC00852 and ovarian cancer after editors found duplicated images across multiple unrelated ...
The editors of BMC Complementary Medicine and Therapies have retracted a 2023 study on the traditional medicinal plant Biarum bovei ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine